GEO Accession viewer

GSM5176915	Sarcoidosis patient B after treated with tofacitinib for six months [SAR2_du_cr]
GSM5176916	Sarcoidosis patient 7 prior to treated with tofacitinib [SAR3_pr_cr]
GSM5176917	Sarcoidosis patient 7 after treated with tofacitinib for six months [SAR3_du_cr]
GSM5176918	Sarcoidosis patient 2 prior to treated with tofacitinib [SAR4_pr_pr]
GSM5176919	Sarcoidosis patient 2 after treated with tofacitinib for six months [SAR4_du_pr]
GSM5176920	Sarcoidosis patient 5 prior to treated with tofacitinib [SAR5_pr_pr]
GSM5176921	Sarcoidosis patient 5 after treated with tofacitinib for six months [SAR5_du_pr]
GSM5176922	Sarcoidosis patient 8 prior to treated with tofacitinib [SAR6_pr_pr]
GSM5176923	Sarcoidosis patient 8 after treated with tofacitinib for six months [SAR6_du_pr]
GSM5176924	Healthy control 1 [re-analysis]
GSM5176925	Healthy control 2 [re-analysis]
GSM5176926	Sarcoidosis patient scRNA-seq 1
GSM5176927	Sarcoidosis patient scRNA-seq 2
GSM5176928	Sarcoidosis patient scRNA-seq 5
GSM5176929	Healthy control scRNA-seq 1 [re-analysis]
GSM5176930	Healthy control scRNA-seq 2 [re-analysis]
GSM5176931	Healthy control scRNA-seq 3 [re-analysis]
GSM5176932	Sarcoidosis patient 1 prior to treated with tofacitinib [Olink Explore 1536 panel]
GSM5176933	Sarcoidosis patient 1 after treated with tofacitinib for six months [Olink Explore 1536 panel]
GSM5176934	Sarcoidosis patient 2 prior to treated with tofacitinib [Olink Explore 1536 panel]
GSM5176935	Sarcoidosis patient 2 after treated with tofacitinib for six months [Olink Explore 1536 panel]
GSM5176936	Sarcoidosis patient 3 prior to treated with tofacitinib [Olink Explore 1536 panel]
GSM5176937	Sarcoidosis patient 3 after treated with tofacitinib for six months [Olink Explore 1536 panel]
GSM5176938	Sarcoidosis patient 4 prior to treated with tofacitinib [Olink Explore 1536 panel]
GSM5176939	Sarcoidosis patient 4 after treated with tofacitinib for six months [Olink Explore 1536 panel]
GSM5176940	Sarcoidosis patient 5 prior to treated with tofacitinib [Olink Explore 1536 panel]
GSM5176941	Sarcoidosis patient 5 after treated with tofacitinib for six months [Olink Explore 1536 panel]
GSM5176942	Sarcoidosis patient 6 prior to treated with tofacitinib [Olink Explore 1536 panel]
GSM5176943	Sarcoidosis patient 6 after treated with tofacitinib for six months [Olink Explore 1536 panel]
GSM5176944	Sarcoidosis patient 7 prior to treated with tofacitinib [Olink Explore 1536 panel]
GSM5176945	Sarcoidosis patient 7 after treated with tofacitinib for six months [Olink Explore 1536 panel]
GSM5176946	Sarcoidosis patient 8 prior to treated with tofacitinib [Olink Explore 1536 panel]
GSM5176947	Sarcoidosis patient 8 after treated with tofacitinib for six months [Olink Explore 1536 panel]
GSM5176948	Sarcoidosis patient 10 prior to treated with tofacitinib [Olink Explore 1536 panel]
GSM5176949	Sarcoidosis patient 10 after treated with tofacitinib for six months [Olink Explore 1536 panel]
GSM5176950	Sarcoidosis patient 1 treated with 5 mg tofacitinib [Olink Explore 1536 panel]
GSM5176951	Sarcoidosis patient 3 treated with 15 mg tofacitinib [Olink Explore 1536 panel]
GSM5176952	Healthy control 1 [Olink Explore 1536 panel]
GSM5176953	Healthy control 2 [Olink Explore 1536 panel]
GSM5176954	Healthy control 3 [Olink Explore 1536 panel]
GSM5176955	Healthy control 4 [Olink Explore 1536 panel]
GSM5176956	Healthy control 5 [Olink Explore 1536 panel]
GSM5176957	Healthy control 6 [Olink Explore 1536 panel]
GSM5176958	Healthy control 7 [Olink Explore 1536 panel]
GSM5176959	Healthy control 8 [Olink Explore 1536 panel]
GSM5176960	Healthy control 9 [Olink Explore 1536 panel]
GSM5176961	Healthy control 10 [Olink Explore 1536 panel]
GSM5176962	Healthy control 11 [Olink Explore 1536 panel]